BT Lab
SKU:BT-AP14259
APOD Polyclonal Antibody
APOD Polyclonal Antibody
Couldn't load pickup availability
This gene encodes a component of high density lipoprotein that has no marked similarity to other apolipoprotein sequences. It has a high degree of homology to plasma retinol-binding protein and other members of the alpha 2 microglobulin protein superfamily of carrier proteins, also known as lipocalins. This glycoprotein is closely associated with the enzyme lecithin:cholesterol acyltransferase - an enzyme involved in lipoprotein metabolism.
The APOD Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of Apolipoprotein D (APOD) in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human APOD protein. The resulting polyclonal antibody exhibits high affinity and specificity towards APOD, making it an ideal tool for various research applications.
The APOD Polyclonal Antibody has been extensively validated for its performance in various immunoassays, including Western blotting, ELISA, and immunohistochemistry. It has been shown to detect APOD protein in a wide range of biological samples, including human serum, plasma, cerebrospinal fluid, and tissue lysates. The antibody has also been tested for its cross-reactivity with other related proteins and has been found to be highly specific for APOD.
This antibody is supplied as a purified IgG fraction, which has been affinity-purified from rabbit serum. It is provided in a liquid form, ready to use for various immunoassays. The APOD Polyclonal Antibody is highly stable and can be stored at -20°C for long-term use.
In summary, the APOD Polyclonal Antibody is a highly specific and sensitive immunological reagent that can be used for the detection and quantification of APOD protein in various biological samples. Its high affinity and specificity make it an ideal tool for various research applications, including biomarker discovery, disease diagnosis, and drug development.
Share
